Cargando…
PO-0951 Effects of COVID-19 during radio(chemo)therapy in head and neck cancer patients
Autores principales: | Bandurska-Luque, A., Winiecki, T., Żmijewska-Tomczak, M., Poźniak-Balicka, R., Adamska, A., Bajon, T., Borowczak, D., Milecki, P., Kaźmierska, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ireland Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629142/ http://dx.doi.org/10.1016/S0167-8140(21)07402-8 |
Ejemplares similares
-
PO-1115 First year survival data on COVID-19 outbreak during radiotherapy course in head and neck cancer
por: Bandurska-Luque, A., et al.
Publicado: (2022) -
Significance of neutrophil to lymphocyte ratio as a predictor of outcome in head and neck cancer treated with definitive chemoradiation
por: Kaźmierska, Joanna, et al.
Publicado: (2023) -
A European survey on the practice of nutritional interventions in head–neck cancer patients undergoing curative treatment with radio(chemo)therapy
por: Bozzetti, Federico, et al.
Publicado: (2021) -
Prediction of Incomplete Response of Primary Tumour Based on Clinical and Radiomics Features in Inoperable Head and Neck Cancers after Definitive Treatment
por: Kaźmierska, Joanna, et al.
Publicado: (2022) -
Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences
por: Becker, Minerva, et al.
Publicado: (2017)